RxDoctor Payments Data

William Holcomb, MD

Ophthalmology · Cullman, ALNPI 1427037605

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.0% of the total across 255 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Alcon at 48.0% of the total. Among ophthalmology clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,649in general payments, 2019–2025

Across 255 payments — averaging $41.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$5K
  • AbbVie$1K
  • Johnson & Johnson Surgical Vision, Inc.$1K
  • NEW World Medical,inc.$1K
  • Biotissue Holdings Inc.$407
  • Sun Pharmaceutical Industries Inc.$196
  • plus $1K from 19 others

What the payments were for

  • Consulting fees$661%
  • Food & beverage$10,53899%
  • Gifts$450%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,649 in reported general payments places this provider in the 90th percentile of 197 ophthalmology providers in Alabama.

See all ophthalmology providers in Alabama

Medicare billing

Part B allowed, 2024
$363,816
Medicare patients
457
Services billed
1,926

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate281$8,717
MoxifloxacinMoxifloxacin Hcl221$8,005
Diclofenac Sodium339$3,677
Latanoprost55$752
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat15$399
Gentamicin Sulfate22$127

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Cullman

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →